Preferred Label : promegestone;
MeSH definition : A synthetic progestin which is useful for the study of progestin distribution and
progestin tissue receptors, as it is not bound by transcortin and binds to progesterone
receptors with a higher association constant than progesterone.;
MeSH synonym : promestone; 17,21-dimethyl-19-nor-4,9-pregnadiene-3,20-dione;
CISMeF synonym : aventis brand of promegestone;
MeSH hyponym : R-5020; surgestone; R 5020; R5020; RU5020; RU-5020; RU 5020;
MeSH CAS label : Estra-4,9-dien-3-one, 17-methyl-17-(1-oxopropyl)-, (17beta)-;
MeSH Related Number : 34184-77-5 (Promegestone);
Registry Number MeSH : 34184-77-5;
MeSH annotation : D25-26;
Wikipedia link : https://en.wikipedia.org/wiki/Promegestone;
Is substance : O;
UNII : 9XE0V2SQYX;
InChIKey : QFFCYTLOTYIJMR-XMGTWHOFSA-N;
Origin ID : D011397;
UMLS CUI : C0033401;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Record concept(s)
Related MeSH Supplementary Concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A synthetic progestin which is useful for the study of progestin distribution and
progestin tissue receptors, as it is not bound by transcortin and binds to progesterone
receptors with a higher association constant than progesterone.
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/surgestone-comprime-de-0-125-mg-0-250-mg-et-0-500-mg
2020
false
false
false
France
French
product recalls and withdrawals
promegestone
---
http://www.has-sante.fr/portail/jcms/c_2610503/fr/surgestone
http://www.has-sante.fr/portail/jcms/c_1050835/surgestone
http://www.has-sante.fr/portail/jcms/c_544791/fr/surgestone
2016
false
France
French
treatment outcome
insurance, health, reimbursement
administration, oral
promegestone
progesterone congeners
promegestone
tablets
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1753159/fr/surgestone
2014
false
France
French
treatment outcome
hormone replacement therapy
postmenopause
drug therapy, combination
insurance, health, reimbursement
administration, oral
promegestone
progesterone congeners
promegestone
tablets
evaluation of the transparency committee
---